News • Imaging

Accutron CT-D Vision - the new essential for contrast

With the launch of the Accutron CT-D Vision, MEDTRON AG once again demonstrates their status as a partner to radiologists. Focusing on the operator's needs, the latest evolution of the Accutron CT-D enhances the usability of its double head CT injector and optimizes its integration into the radiology environment.

Photo
Accutron CT-D Vision
Source: Medtron AG

The modernized user interface makes the Accutron CT-D Vision even more user-friendly. It improves comfort, simplifies workflows and helps to improve patient care. Larger touchscreens on the injection unit and remote control increase readability and reduce eye fatigue.

Additionally, the Accutron CT-D Vision benefits from MEDTRON's intelligent Battery Management System, which optimizes battery charge duration and further increases operational availability. New medical-grade casters provide increased mobility by allowing the injector to be moved effortlessly and quietly around the exam room floor.

For optimal integration into the radiology environment, the Accutron CT-D Vision is also equipped with a new Injection Data Sharing (IDS) option. The IDS software option allows direct connection to RIS and PACS via a DICOM standard, enabling full traceability, documentation and analysis of contrast administration in computed tomography. 


Source: Medtron AG

09.06.2021

Related articles

Photo

News • Coronary artery disease detection

Low-dose chest CT may detect more than just lung cancer

As new research shows, low-dose chest computed tomography (CT) can identify coronary artery calcium, a strong risk factor for coronary artery disease (CAD), in patients without cardiac symptoms.

Photo

Sponsored • Diagnostic technology

New 640-slice CT delivered to the heart of Italy

United Imaging are excited to share that, in partnership with Fora S.p.A., an industry leader with over 50 years of expertise in delivering advanced diagnostic technologies to the Italian market,…

Photo

News • System designed for radiation oncology

Spectral 4DCT imaging receives FDA clearance

Royal Philips announced a major advance in radiation oncology with 510(k) clearance from the US Food and Drug Administration (FDA) for its new detector-based spectral CT radiotherapy solution.

Related products

Subscribe to Newsletter